Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Progress in pharmacogenetics: consortiums and new strategies.

Drug metabolism and personalized therapy - 1 Mar 2016

Maroñas Olalla, Latorre Ana, Dopazo Joaquín, Pirmohamed Munir, Rodríguez-Antona Cristina, Siest Gérard, Carracedo Ángel, LLerena Adrián

Abstract excerpt

Pharmacogenetics (PGx), as a field dedicated to achieving the goal of personalized medicine (PM), is devoted to the study of genes involved in inter-individual response to drugs. Due to its nature, PGx requires access to large samples; therefore, in order to progress, the formation of collaborative consortia seems to be crucial. Some examples of this collective effort are the European Society of Pharmacogenomics...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to High-Throughput Screening Assays
Share to Patient Care Team

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cooperative Behavior

Share to Genome-Wide Association Study

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Source

Identifiers

PMID: 26913460
DOI: 10.1515/dmpt-2015-0039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Progress in pharmacogenetics: consortiums and new strategies.PMID 26913460Read ↗

Pharmacogenetics in Italy: current landscape and future prospects.Semantic proximity Read ↗

Pharmacogenomics guidelines: Current status and future developmentSemantic proximity Read ↗

Progress towards the integration of pharmacogenomics in practice.Semantic proximity Read ↗

Developments in pharmacogenetics, pharmacogenomics, and personalized medicineSemantic proximity Read ↗

Pharmacogenetics: An Important Part of Drug Development with A Focus on Its ApplicationSemantic proximity Read ↗

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.Semantic proximity Read ↗

A SNPshot: pharmacogenetics and the future of drug therapy.Semantic proximity Read ↗

Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiativesSemantic proximity Read ↗

Global genetic analysis.Semantic proximity Read ↗

PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of PharmacogeneticsSemantic proximity Read ↗

Pharmacogenomics: Current State-of-the-ArtSemantic proximity Read ↗

The role and impact of SNPs in pharmacogenomics and personalized medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.